Mucosolvan (Ambroxol Hydrochloride)

Ambroxol stimulates the production of surfactant in the respiratory epithelium and enhances ciliary activity, which together lower mucus viscosity and improve mucociliary clearance. The drug also has a mild local anti‑inflammatory effect and can increase serous fluid secretion, further diluting mucus and facilitating expectoration.

The appropriate dose of Mucosolvan is determined by a qualified healthcare professional based on the patient’s age, condition severity, and overall health status. Prescribers follow local prescribing guidelines and adjust the regimen as needed; patients should follow the specific instructions provided by their clinician.

Safety data for ambroxol during pregnancy are limited, so the product should be used only if the potential benefit justifies any potential risk to the fetus. While small amounts may be excreted in breast milk, caution is advised for nursing mothers, and they should consult their healthcare provider before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team then replies with pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Both ambroxol (Mucosolvan) and acetylcysteine act to reduce mucus thickness, but ambroxol additionally stimulates surfactant production and has a mild anti‑inflammatory effect. Acetylcysteine works primarily by breaking disulfide bonds in mucus glycoproteins. Choice of agent often depends on patient tolerance, specific clinical scenario, and physician preference.

Mucosolvan should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the container tightly closed and out of reach of children. Do not store in bathrooms or near heat sources.

Mucosolvan is taken orally, usually with a glass of water. The tablet (or liquid, if supplied) should be swallowed whole and not chewed unless the product label specifically advises otherwise. Administration timing (e.g., before meals) follows the prescribing clinician’s instructions.

Serious adverse reactions, although rare, include severe allergic responses such as rash, urticaria, angioedema, Stevens‑Johnson syndrome, and anaphylaxis. Hepatic enzyme elevations and blood dyscrasias like eosinophilia or neutropenia have also been reported. Patients should seek immediate medical attention if they experience any signs of a severe allergic reaction or unexplained systemic symptoms.

Mucosolvan is contraindicated in individuals with known hypersensitivity to ambroxol or any of the excipients in the formulation. Patients with severe renal impairment should use it only under medical supervision, and those with a history of severe allergic reactions to mucolytics should avoid it. Pregnant or breastfeeding women should consult their healthcare provider before starting therapy.